These cell lines were validated by EGFR expression at the mRNA and protein levels, phosphorylation of EGFR and its downstream signaling pathways, drug sensitivity to EGFR-TKI, cell proliferation in vitro and tumor growth in vivo (Figs. S2, S3). The gene discussed is EGFR; the disease is neoplasm.